• 12/17/2014

    “Super Powers”

    Byline article by Dr Tim Muller on renewal of the pharmaceutical industry with the development of supergenerics. Demographics, progress in healthcare and greater possibilities to treat patients have caused developed countries’ healthcare costs to rise dramatically over the past decades. Rapid penetration of generics has been a key development in order to achieving savings. However the pharmaceutical landscape is undergoing changes and new forms of treatment are underway, in the form of supergeneric products, and more precisely with the use auto-injection devices.

    Read more
  • Crossject reports positive results from bioequivalence study with neddle-free ZENEO® Methotrexate

    Crossject, the creator of ZENEO®, a needle-free injection system, announces the similarity betweeen the ZENEO® Methotrexate neddle-free injection system and the current injectable formulation. 

    Read more


  • 06/10/2015

    Crossject will be present at The French Life Science days in New-York

    The second edition of the « French Life Science Days » aims to bring together listed French companies and North American financial community in order to allow innovative companies to promote their business to Healthcare investors in the United-States.

    Read more
  • 12/09/2014

    Crossject will be present at Bio USA 2015

    Meet us in BIO International Convention 2015 will take place in Philadelphia, June 15th to 18th.
    Contact Tim Muller: or  / Mobile +33 (0)645523540 / +33(0)602510791 / skype id: timotheemuller

    Read more


Discover our needle-free self injectable solution

The desire for safer and more user-friendly injection device to prevent needle-stick injuries...

more videos